KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Nov 20, 2026 >>  ABB India 6915  [ -0.62% ]  ACC 1276.45  [ 0.65% ]  Ambuja Cements 399.3  [ 0.58% ]  Asian Paints 2603.35  [ 0.37% ]  Axis Bank 1447  [ 2.05% ]  Bajaj Auto 10778  [ -0.34% ]  Bank of Baroda 286.6  [ 0.39% ]  Bharti Airtel 2155.5  [ 0.39% ]  Bharat Heavy 433  [ -0.23% ]  Bharat Petroleum 312  [ 1.46% ]  Britannia Industries 4890  [ 0.42% ]  Cipla 1414.95  [ -0.07% ]  Coal India 390  [ -0.51% ]  Colgate Palm 1760.6  [ -0.81% ]  Dabur India 394  [ 0.77% ]  DLF 783.5  [ 2.14% ]  Dr. Reddy's Lab. 1390.5  [ -0.54% ]  GAIL (India) 191.45  [ -0.21% ]  Grasim Industries 3102.4  [ -0.07% ]  HCL Technologies 1337  [ 0.41% ]  HDFC Bank 845.25  [ 3.02% ]  Hero MotoCorp 5523  [ -0.59% ]  Hindustan Unilever 2054  [ -0.96% ]  Hindalco Industries 930.3  [ 2.34% ]  ICICI Bank 1641  [ 2.22% ]  Indian Hotels Co. 911.55  [ 2.22% ]  IndusInd Bank 1005  [ 8.88% ]  Infosys 1096.4  [ 0.54% ]  ITC 298.8  [ -0.73% ]  Jindal Steel 1125.35  [ 4.31% ]  Kotak Mahindra Bank 516  [ 3.08% ]  L&T 4201  [ -0.10% ]  Lupin 2010  [ 0.55% ]  Mahi. & Mahi 3541.5  [ 0.89% ]  Maruti Suzuki India 13990.3  [ 2.88% ]  MTNL 24.28  [ -2.18% ]  Nestle India 1326  [ 1.58% ]  NIIT 69.47  [ -0.97% ]  NMDC 69  [ 1.16% ]  NTPC 320.8  [ -1.29% ]  ONGC 223.5  [ -0.45% ]  Punj. NationlBak 155.2  [ -0.13% ]  Power Grid Corpn. 268.5  [ 1.70% ]  Reliance Industries 1375.1  [ 0.37% ]  SBI 1164.95  [ 0.60% ]  Vedanta 237.6  [ -2.38% ]  Shipping Corpn. 256.7  [ 2.87% ]  Sun Pharmaceutical 1885.1  [ -0.94% ]  Tata Chemicals 639.15  [ -1.64% ]  Tata Consumer 1155  [ 1.18% ]  Tata Motors Passenge 266.05  [ 1.04% ]  Tata Steel 177.75  [ -1.69% ]  Tata Power Co. 340  [ 0.00% ]  Tata Consult. Serv. 2375  [ 1.21% ]  Tech Mahindra 1742  [ 1.10% ]  UltraTech Cement 12926.4  [ 2.75% ]  United Spirits 1461  [ -0.27% ]  Wipro 185.5  [ 0.60% ]  Zee Entertainment 71.4  [ -0.07% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

JFL LIFE SCIENCES LTD.

20 November 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE0LA901015 BSE Code / NSE Code / Book Value (Rs.) 12.12 Face Value 10.00
Bookclosure 10/03/2026 52Week High 14 EPS 0.97 P/E 12.75
Market Cap. 81.50 Cr. 52Week Low 9 P/BV / Div Yield (%) 1.02 / 0.00 Market Lot 6,000.00
Security Type Other

DIRECTOR'S REPORT

You can view full text of the latest Director's Report for the company.
Year End :2026-03 

Your directors are pleased to present Sixteenth Annual Report on the business and
operations of the Company together with the Audited Statements of Accounts for the
financial year ended on March 31st, 2026 and other accompanying reports, notes and
certificates.

1. FINANCIAL SUMMARY AND HIGHLIGHTS:

The financial performance of the company for the financial year ended on March 31,
2026 is given below:

(Amount in Lakhs.)

Particulars

31 March, 2026

31st March, 2025

Revenue from Operations

13138.26

8204.23

Other Income

6.90

1.01

Total Revenue

13145.16

8205.24

Less: Total Expenses

12285.26

7591.70

Profit Before Tax

859.90

613.54

Less Current Income Tax

215.82

152.78

Less Previous year adjustment of Income
Tax

-

Less Deferred Tax

3.98

44.90

Net Profit after Tax

640.10

415.50

Earnings per share (Basic)

1.94

1.26

Earnings per Share (Diluted)

1.94

1.26

The Key highlights pertaining to the business of the Company for the Year 2025-26
have been given hereunder:

The Company has turnover of 13,138.26 (in lakhs) and the company has book Net
Profit of Rs. 640.10 (in lakhs) for the year under review.

The Earnings per Share of the financial year under review is 1.94.

Furthermore, your director assured that the Company will achieve its strategic
objectives of sustainable and profitable growth by improving the product excellence,
exploring markets and delivering customer delight in the year to come.

2. DIVIDEND:

The Board of the Company not recommended any dividend due to future growth and
expansion for the financial year 2025-26.

3. TRANSFER TO IEPF:

The Company is not required to transfer any amount to IEPF Account.

4. TRANSFER TO RESERVES:

Whole of the Net Profit earned has been transferred to the reserves for the year under
review.

5. SHARE CAPITAL
Authorized Capital:

The Authorized Share capital of the Company as on March 31, 2026 is Rs.
67,50,00,000

Issued, Subscribed and Paid-up Capital:

The Issued, Subscribed and Paid-up Capital of the Company is Rs. 32,99,53,230.

Further the company has received In-principal approval for 2,19,96,882 bonus shares
on May 06, 2025 and Listing approval on June 09, 2025.

RIGHTS ISSUE

During the year under review, the Board of Directors approved the issuance of
3,29,95,323 fully paid-up Equity Shares of face value of Rs. 10/- each at an issue price
of Rs. 10/- per Equity Share, aggregating to Rs. 3,299.53 Lakhs, to the existing equity
shareholders of the Company on a rights basis in accordance with the applicable
provisions of the Companies Act, 2013, the rules made thereunder, the Securities and
Exchange Board of India (Issue of Capital and Disclosure Requirements] Regulations,
2018, and other applicable laws and regulations.

However, the Rights Issue did not receive the minimum subscription amount, as the
Company did not receive the subscription money from the eligible shareholders
within the stipulated period. Consequently, in accordance with the applicable
provisions of law and the terms of the Rights Issue, the Rights Issue was treated as
devolved and no equity shares were allotted pursuant to the said Rights Issue.

Accordingly, the Company has devolved the Rights Issue, and the issued, subscribed
and paid-up share capital of the Company remains unchanged on account of the
aforesaid Rights Issue.

6. DETAILS OF HOLDING/SUBSIDIARY/ASSOCIATE COMPANIES/ JOINT
VENTURES:

The Company does not have any Holding/Subsidiary/Associate Company/Joint
Ventures.

Statement Containing Salient Features of Financial Statements of Associate
Company
:

Your Company is not having any Associate Company and hence the statement
containing the salient feature of the financial statement of a company's associate
Company under the first proviso to subsection (3] of section 129 in the prescribed
Form AOC-1 does not form part of Directors' Report.

Details of New Subsidiary/ loint Ventures/Associate Companies:

There are no new Subsidiary/Joint Ventures/Associate Companies of the Company
during the year under review.

Details of the Company who ceased to be its Subsidiary/ loint Ventures/
Associate Companies:

Sr no.

Name of
Company

Subsidiary / Joint
Venture /

Associate Company

Date of cessation of
Subsidiary /

Joint Venture /
Associate Company

-

-

-

-

7. BOARD OF DIRECTORS, MEETINGS AND ITS COMMITTEES:

• APPOINTMENTS ON BOARD:

> Ms. Khyati Bhavya Shah was appointed as Additional Non-Executive
Independent Director w.e.f11.08.2025 and regularized on 26.09.2025.

> Mr. Smiral Ashwinkumar Patel, is recommended to be re-appointed as a
Managing Director of the company with effect from 18th January, 2027, Subject
to approval of shareholders in the ensuing Annual General Meeting.

> Mrs. Tejal Smiral Pate; is recommended to be re-appointed as a Managing
Director of the company as a Whole Time Director of the company with effect
from 18th January, 2027, Subject to approval of shareholders in the ensuing
Annual General Meeting.

> Ms. Sonu Lalitkumar Jain, is recommended to be re-appointed as a non¬
executive independent Director of the company with effect from 18th January,
2027, Subject to approval of shareholders in the ensuing Annual General
Meeting.

> Ms. Bhavna Basantbhai Shah,, is recommended to be re-appointed as a non¬
executive independent Director of the company with effect from 10th February
,2027, Subject to approval of shareholders in the ensuing Annual General
Meeting.

> Ms. Amita Chhaganbhai Pragada appointed as additional non-executive
Independent Director of the company on 8Th April,2025 and resigned on 25th
July, 2025.

• NUMBER OF BOARD MEETINGS:

During the year under review i.e. Financial Year 2025-26, 14 (Fourteen] Board
meetings were held.

4th April, 2025, 8th April, 2025, 22nd April, 2025, 19th May, 2025, 25th July,2025,
11th August,2025,1St September,2025, 1St October,2025, 30th October,2025, 11th
November, 2025, 29th January, 2026,27Th February,2026, 4Th March,2026 and
24Th March, 2026.

• ATTENDANCE OF DIRECTORS AT BOARD MEETING AND ANNUAL GENERAL
MEETING (AGM):

Name of the Director

Nature of
Directorship

Number of

Board

Meeting

attended

during the

year

Whether
attended
last AGM
26/09/2025

SMIRAL

ASHWINKUMAR PATEL

Managing Director

14

Yes

TEJAL SMIRAL PATEL

Executive Director

14

Yes

MANISHKUMAR
JASVANTLAL PATEL

Non-Executive

Director

14

Yes

SONU LALITKUMAR
JAIN

Non-Executive-

Independent

Director

14

Yes

BHAVNA BASANTBHAI
SHAH

Non-Executive-

Independent

Director

14

Yes

KHYATI BHAVYA SHAH

Non-Executive-

Independent

Director

08

Yes

AMITA CHHAGANBHAI
PARAGADA

Non-Executive-

Independent

Director

02

No

• DIRECTOR RETIRED BY ROTA TION:

Mr. MANISHKUMAR JASVANTLAL PATEL (DIN: 09499355), who retires by
rotation and being eligible, offers himself for re-appointment as Director in this
AGM.

• MEETING OF INDEPENDENT DIRECTORS:

Pursuant Regulation 25(3] of the SEBI (Listing Obligations and Disclosure
Requirements] Regulations 2015, the Separate meeting of the Independent

Directors of the Company was held on March 24, 2026 at registered office of the
Company.

• CHANGE IN KEY-MANA GERIAL PERSONNEAL:

There is no change in the Key Managerial Personnel of the Company.

• DECLARA TION BY INDEPENDENT DIRECTORS:

All Independent Directors have given declarations to the effect that they meet the
criteria of independence as laid down under Section 149(6] of the Companies Act,
2013 read with Regulation 16 of SEBI (Listing obligations and Disclosures
Requirements], Regulations 2015. In the opinion of the Board, Independent
Directors fulfill the conditions specified in the Act, Rules made there under and
Listing Regulations.

• FORMAL ANNUAL EVALUATION OF THE PERFORMANCE OF THE BOARD, ITS
COMMITTEES AND INDIVIDUAL DIRECTORS:

During the year, the Board carried out an Annual Evaluation of its own
performance and the performance of individual Directors, as well as evaluation of
the Committees of the Board under the provisions of Section 134 (3)(p) of the Act,
relevant Rules, as prescribed. They were satisfied with the overall performance of
the Directors individually and that the Directors generally met their expectations
of performance.

• STA TEMENT OF BOARD ON INDEPENDENT DIRECTOR:

All the Independent directors appointed during the year under review are of
utmost integrity, expertise and experience and has passed the proficiency test
conducted by the Indian Institute of Corporate Affairs.

• COMMITTEES OF THE BOARD:

The provisions of the Companies Act, 2013 and the Securities Exchange Board of
India (Listing Obligations and Disclosures Requirements], Regulation, 2015 have
prescribed and mandated Forming of Committees of the Board for efficient
working and effective delegation of work and to ensure transparency in the
practices of the Company.

Accordingly, the Committees formed by the Board are as follows:

1. Audit Committee:

Pursuant to Section 177 of the Companies Act, the Board has formed an Audit
Committee. The details of which is disclosed herewith.

The Audit Committee of your Company was formed with the purpose of ensuring
Transparency, Efficiency & Accountability in the transactions of the Company.

Further to recommend Appointment & Remuneration of the Statutory Auditors
of the Company, examining the Financial Statements, approving Related Party
transactions, carrying out valuation of various Undertakings/Assets of the
Company etc.

During the year, the Audit Committee Constituted of the following persons:

Sr

No.

Name of Member

Designation

Designation in
Committee

No. of

Meeting

Attended

1

Mr. Manishkumar
Patel

Non-executive

Director

Member

6

2

Mrs Bhavna Shah

Independent

Director

Chairperson

6

3

Ms. Sonu Jain

Independent

Director

Member

6

The Audit Committee is constituted and has met Six times during the Financial
Year 2025-26 on 8th April, 2025,22nd April, 2025, 11Th August, 2025, 1
st
September, 2025, 11
Th November, 2025 and 29th January, 2026.

2. Nomination and Remuneration Committee:

The Company pursuant to Section 178(1] of the Companies Act, 2013 has formed
the Nomination and Remuneration Committee. The details of which is disclosed
herewith. The policy is available on the following web-link of the Company:
https://www.ifllifesciences.com/

The Committee is, inter-alia has been formed to identify persons who are
qualified to become Directors of the Company and who may be appointed in the
Senior Management along with the evaluation of Directors performance,
formulating criteria for determining positive attributes and independence of a
director and recommending policy relating to the remuneration of the Directors,
Key Managerial Personnel and other employees and granting of Employee Stock
Options to eligible employees.

During the year, the Nomination & Remuneration Committee constituted of the
following persons:

SRN

Name of Member

Designation

Designation

in

Committee

No. of

Meeting

Attended

1

Mr. Manishkumar
Patel

Non¬

executive

Director

Member

2

2

Mrs Bhavna Shah

Independent

Director

Chairperson

2

3

Ms. Sonu Jain

Independent

Director

Member

2

The Nomination Remuneration Committee is constituted and has met Twice
during the Financial Year 2025-26 i.e. on 8th April, 2025 and 11Th August, 2025.

3. Stakeholders Relationship Committee:

The Board has in accordance with the provisions of Section 178(5] of the
Companies Act, 2013 constituted Stakeholder Relationship Committee. The
details of which is disclosed herewith. The Stakeholders Relationship Committee
has been formed to resolve the grievances of various stakeholders of the
Company. Its scope of work includes overseeing the performance of the RTA and
take note of the complaints received, issuing of duplicate share certificates in case
of loss/ theft or torn certificate, redressal of issues related to non-receipt of
dividend/Annual report, etc.

The Committee, inter alia, started overseeing and reviewing all matters
connected with the shares and looks into shareholders complaints.

No complaints were received by the Company from the shareholders / investors
during the Financial Year 2025-26 and no investor complaints were outstanding
as on 31st March 2026.

During the year, the Stakeholder Relationship Committee constituted of the
following persons:

SRN

Name of Member

Designation

Designation

in

Committee

No. of

Meeting

Attended

1

Mr. Manishkumar
Patel

Non¬

executive

Director

Member

4

2

Mrs Bhavna Shah

Independent

Director

Chairperson

4

3

Ms. Sonu Jain

Independent

Director

Member

4

The Stakeholder Relationship Committee is constituted and has met four times
during the Financial Year 2025-26 on 21
st April, 2025, 17Th July, 2025, 13Th
October, 2025, and 7Th January, 2026.

8. RISK MANAGEMENT POLICY:

Risk Management is the process of identification, assessment and prioritization of
risks followed by coordinated efforts to minimize, monitor and mitigate/control
the probability and/or impact of unfortunate events or to maximize the
realization of opportunities. The Company has laid down a comprehensive Risk
Assessment and Minimization Procedure which is reviewed by the Board from
time to time. These procedures are reviewed to ensure that executive
management controls risk through means of a properly defined framework. The
major risks have been identified by the Company and its mitigation
process/measures have been formulated in the areas such as business, project
execution, event, financial, human, environment and statutory compliance.

9. THE VIGIL MECHANISM/ WHISTLE BLOWER POLICY:

Your Company believes in promoting a fair, transparent, ethical and professional
work environment. The Board of Directors of the Company has established a
Whistle Blower Policy & Vigil Mechanism in accordance with the provisions of
the Companies Act, 2013 and the SEBI (LODR) Regulations, 2015 for reporting
the genuine concerns or grievances or concerns of actual or suspected, fraud or
violation of the Company's code of conduct. The said Mechanism is established
for directors and employees to report their concerns. The policy provides the
procedure and other details required to be known for the purpose of reporting
such grievances or concerns.

The policy is available on the following web-link of the Company:
https://www.ifllifesciences.com/

10. CORPORATE SOCIAL RESPONSIBILITY:

Your Company has in place the CSR Committee which performs the functions as
mandated under the Act. As a good corporate citizen, the Committee has adopted
and approved the policy on CSR to improve the welfare of the stakeholders and
the Society as a whole.

The Report on CSR Activities including therein a brief outline of the CSR policy of
the Company, activities / projects / contributions / initiatives undertaken by the
Company on CSR activities during the year under review and other related details
are set out in "Annexure-I" which forms part of this Board of Directors' Report.

However, during the year, the Company was not required to spend on CSR
activities, as its net profit, turnover, and net worth were below the thresholds
prescribed under Section 135 of the Companies Act, 2013. Accordingly, the
amount during the year spent by the Company on CSR, in excess of the required
obligation, will be set off against future CSR obligations in accordance with
applicable rules.

11. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION. FOREIGN
EXCHANGE EARNINGS AND OUTGO:

The information pertaining to conservation of energy, technology absorption,
foreign exchange Earnings and outgo as required under Section 134 (3)(m) of the

Companies Act, 2013 read with Rule 8(3] of the Companies (Accounts) Rules,
2014 regarding conservation of energy and technology absorption is Nil.

(A) Conservation of energy-

the steps taken or impact on conservation of energy;

NIL

the steps taken by the company for utilising alternate sources of
energy

NIL

the capital investment on energy conservation equipment's

NIL

(B) Technology absorption-

the efforts made towards technology absorption;

NIL

the benefits derived like product improvement, cost reduction,
product development or import substitution;

NIL

in case of imported technology (imported during the last three years
reckoned from the beginning of the financial year]-

(a] the details of technology imported;

(b] the year of import;

(c] whether the technology been fully absorbed;

(d] if not fully absorbed, areas where absorption has not taken place,
and the reasons thereof; and

(iv] The expenditure incurred on Research and Development.

NA

(C) Foreign exchange earnings and Outgo-

The Foreign Exchange earned in terms of actual inflows during the
year

NA

The Foreign Exchange outgo during the year in terms of actual
outflows.

NA

12. OTHER STATUTORY DISCLOSURES:

Disclosure of Remuneration paid to Director and Key Managerial Personnel
and Employees:

The details with regard to payment of remuneration to Director and Key
Managerial Personnel pursuant to Section 197(12] of Companies Act, 2013 is
provided in separate annexure to the Report as "Annexure-II", which forms part
of this Report.

Remuneration to Employees

None of the employee has received remuneration exceeding the limit as stated in
rule 5(2] of the Companies (Appointment and Remuneration of Managerial
Personnel] Rules, 2014.

Particulars of contracts or arrangements with related parties:

All Transactions/Contracts/Arrangements entered into by the Company with
Related Party (ies) as provided under the provisions of Section 2 (76] of the

Companies Act, 2013, during the Financial Year under review were in ordinary
course of business and on an Arm's Length Basis.

Further, none of these Contracts / Arrangements / Transactions with Related
Parties could be considered material in nature as per the thresholds given in Rule
15(3] of the Companies (Meetings of Board and its Powers) Rules, 2014 and
hence no disclosure is required to be given in this regard.

The details are disclosed in Form AOC-2 which is annexed as "Annexure-IH",
which forms part of this Report.

Particulars of Loan, Guarantee and Investments under Section 186 of the
Act:

Pursuant to the provisions of Section 186 of the Companies Act, 2013, read with
The Companies (Meetings of Board and its Powers] Rules, 2014 as amended from
time to time (including any amendment thereto or re-enactment thereof for the
time being in force], Loans, guarantees and investments covered under Section
186 of the Companies Act, 2013 form part of Financial Statements provided in
this Annual Report.

Deposits

The Company has not accepted any deposits from the public within the meaning
of Section 73 of the Companies Act, 2013 read with the Companies (Acceptance
of Deposits] Rules, 2014.

Board Diversity

The Company recognizes and embraces the importance of a diverse board in its
success. The Company believes that a truly diverse board will leverage
differences in thought, perspective, knowledge, skill, regional and industry
experience, cultural and geographical background, age, ethnicity, race and
gender, which will help the Company to retain its competitive advantage.

Disclosures as per the Sexual Harassment of Women at Workplace
(Prevention, Prohibition and Redressal) Act, 2013:

The Company has zero tolerance for sexual harassment at workplace and has
adopted a Policy on Prevention, Prohibition and Redressal of Sexual Harassment
at Workplace in line with the provisions of the Sexual Harassment of Women at
Workplace (Prevention, Prohibition and Redressal] Act, 2013 and the Rules made
there under for prevention and Redressal of complaints of sexual harassment at
workplace.

The objective of this policy is to lay clear guidelines and provide right direction
in case of any reported incidence of sexual harassment across the Company's
offices and take appropriate decision in resolving such issues.

During the financial year 2025-26, the Company has not received any compliant
on sexual harassment. The policy is available on the website of the Company.

Material changes and commitments affecting the financial position of the
Company:

During the period under review from April 01, 2025 to March 31, 2026, there
were no material changes and commitments undertaken by the Company which
affected the financial position of the Company.

Significant and material orders passed by the regulators or Courts or
Tribunals impacting the going concern status and Company's Operations in
Future:

As per the information available with the Board of Directors, there were no such
orders passed against the Company.

Change in the Nature of Business.

There is no change in Business during the year.

Change in Name.

There is no change in name of the company.

Internal Financial Control Systems and their adequacy.

Internal Financial Controls are an integrated part of the risk management
process, addressing financial and financial reporting risks. The internal financial
controls have been documented, digitized and embedded in the business
processes.

Assurance on the effectiveness of internal financial controls is obtained through
management reviews, control self- assessment, continuous monitoring by
functional experts as well as testing of the internal financial control systems by
the internal auditors during the course of their audits.

We believe that these systems provide reasonable assurance that our internal
financial controls are designed effectively and are operating as intended.

Disclosure Under Section 43(A) (II) Of the Companies Act, 2013:

The Company has not issued any shares with differential rights and hence no
information as per provisions of Section 43 (a] (ii) of the Act read with Rule 4 (4]
of the Companies (Share Capital and Debenture] Rules, 2014 is furnished.

Disclosure Under Section 54(1)(D) Of the Companies Act, 2013.

The Company has not issued any sweat equity shares during the year under
review and hence no information as per provisions of Section 54 (1] (d) of the Act
read with Rule 8 (13) of the Companies (Share Capital and Debenture] Rules,
2014 is furnished.

Disclosure Under Section 62(1)(B) Of the Companies Act, 2013.

The Company has not issued any equity shares under Employees Stock Option
Scheme during the year under review and hence no information as per provisions
of Section 62 (1] (b] of the Act read with Rule 12 (9] of the Companies (Share
Capital and Debenture] Rules, 2014 is furnished.

Disclosure under Section 67(3) Of the Companies Act, 2013.

During the year under review, there were no instances of non-exercising of voting
rights in respect of shares purchased directly by employees under a scheme
pursuant to Section 67 (3] of the Act read with Rule 16 (4] of Companies (Share
Capital and Debentures] Rules, 2014 is furnished.

13. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS.

The Company has not provided any loans or made any investments or provided
any guarantees and securities for the year under review under section 185 and
186 of the Companies Act, 2013.

14. MANAGEMENT DISCUSSION AND ANALYSIS:

The Management Discussion and Analysis Report on the operations of the
Company as required pursuant to Part B of Schedule V of SEBI (Listing
Obligations and Disclosure Requirements] Regulations, 2015 is annexed hereto
and marked as “Annexure - IV" and forms part of this Report.

15. SECRETARIAL STANDARDS OF ICSI.

Your Company is in compliance with the Secretarial Standards on Meetings of the
Board of Directors (SS - 1] and General Meetings (SS - 2] issued by The Institute
of Company Secretaries of India and approved by the Central Government.

16. AUDITORS

Statutory Auditors:

The Auditor's report given by M/s. Doshi Doshi & Co, Chartered Accountants
(FRN: 153683W], on the Financial Statements of your Company, for the year
ended March 31, 2026, forms part of the Annual Report.

There is no qualification, reservation or adverse remark or any disclaimer in their
Report. In accordance with the Section 40 of the Companies (Amendment] Act,
2017 (corresponding to Section 139 of the Act], the requirement of ratification of
the appointment of the Statutory Auditor in every Annual General Meeting of the
Company during the tenure of appointment has been dispensed with. Hence, the
matter has been placed as an agenda item in the AGM Notice for the approval of
the shareholders.

Details in Respect of frauds reported by the Auditors under Section 143(12)
of Companies Act, 2013:

There are no frauds reported by the Auditor which are required to be disclosed
under Section 143(12] of Companies Act, 2013.

Secretarial Auditor:

The Company has appointed M/S. Prachi Lad & Associates, Practicing Company
Secretary, as a Secretarial Auditor of the Company, according to the provision of
Section 204 of the Companies Act, 2013 read with Companies Rules for the
purpose of conducting Secretarial Audit of Company for the financial year 2025¬
26 to 2029-30. The Report of the Secretarial Audit is annexed herewith as
“Annexure V".

17. INTERNAL AUDIT AND INTERNAL CONTROL SYSTEMS:

The Company has an internal control system, commensurate with the size, scale
and complexity of its operations. This ensures that all transactions are
authorized, recorded and reported correctly, and assets are safeguarded and
protected against loss from unauthorized use or disposition. The Company has
adequate internal controls for its business processes across departments to
ensure efficient operations, compliance with internal policies, applicable laws
and regulations, protection of resources and assets and appropriate reporting of
financial transactions.

The Company has Internal Audit function which is empowered to examine the
adequacy and compliance with policies, plans and statutory requirements.

It comprises of experienced professionals who conduct regular audits across the
Company's operations. The Company has also appointed a firm of Chartered
Accountants as Internal Auditors, who reviews the various functions of the
Company thoroughly and report to the Audit Committee.

18. PREVENTION OF INSIDER TRADING:

The Company has adopted a Code of Conduct for Prevention of Insider Trading
pursuant to new SEBI (Prohibition & Insider Trading] Regulation 2015 in place
of SEBI (Prohibition & Insider Trading] Regulation 1992 with a view to regulate
trading in securities by the Directors and designated employees of the Company.
The Code requires pre-clearance for dealing in the Company's shares and
prohibits the purchase or sale of Company shares by the Directors and the
designated employees while in possession of unpublished price sensitive
information in relation to the Company and during the period when the 'Trading
Window' is closed. The Board is responsible for implementation of the Code. All
Directors and the designated employees have confirmed compliance with the
Code.

19. SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION,
PROHIBITION AND REDRESSAL) ACT, 2013:

Disclosure under Section 22 of the Sexual Harassment of Women at Workplace
(Prevention, Prohibition and Redressal] Act, 2013:

Pursuant to Section 22 of the Sexual Harassment of Women at Workplace
(Prevention, Prohibition and Redressal] Act, 2013 the company has setup the
Internal complaints committee and the said committee has framed the policy
“Prevention of Sexual Harassment” on prevention, prohibition and Redressal of
complaints related to sexual harassment of women at the workplace. All women
employees whether permanent, temporary or contractual are covered under the
above policy.

Disclosure of complaints during the year:

(a] Number complaints of sexual harassment received in the year: Nil

(b] Number of complaints disposed off during the year: Nil

(c] Number of cases pending for more than ninety days: Nil

However, during the year no complaints were received by the Internal
Complaints committee for sexual harassment from any of the women employees
of the company.

20. MATERNITY BENEFIT PROVIDED BY THE COMPANY UNDER MATERNITY
BENEFIT ACT 1961:

The Company declares that it has duly complied with the provisions of the
Maternity Benefit Act, 1961. All eligible women employees have been extended
the statutory benefits prescribed under the Act, including paid maternity leave,
continuity of salary and service during the leave period, and post-maternity
support such as nursing breaks and flexible return-to-work options, as
applicable. The Company remains committed to fostering an inclusive and
supportive work environment that upholds the rights and welfare of its women
employees in accordance with applicable laws.

21. DIRECTORS' RESPONSIBILITY STATEMENT

Pursuant to the provisions of Section 134 (5] of the Companies Act, 2013, your
Directors, to the best of their knowledge and belief and according to information
and explanation obtained by them, confirm that:

(a) In the preparation of the annual accounts for the year ended on 31st March
2026, the applicable accounting standards had been followed along with
proper explanation relating to material departures;

(b) The Directors had selected such accounting policies and applied them
consistently and made judgments and estimates that are reasonable and
prudent so as to give a true and fair view of the state of affairs of the
Company at the end of the financial year and of the profit and loss of the
company for that period;

(c) The Directors had taken proper and sufficient care for the maintenance of
adequate accounting records in accordance with the provisions of this Act
for safeguarding the assets of the company and for preventing and
detecting fraud and other irregularities;

(d) The Directors had prepared the annual accounts on a going concern basis;
and

(e) The Directors had laid down Internal Financial Controls to be followed by
the Company and that such internal financial controls are adequate and
were operating effectively.

22. DISCLOSURE ABOUT DISQUALIFICATION:

None of the Directors of the Company are disqualified under Section 164 (2) of
The Companies Act, 2013.

23. COST RECORDS

The company under sub-section (1) of section 148 of the Companies Act, 2013, is
engaged in the production of the goods or providing services, as specified in
“Regulated Sector” of the Act having an overall turnover from all its products and
services of rupees thirty five crore or more during the immediately preceding
financial year, includes cost records for such products or services in their books
of accounts as required to maintain cost accounts and records.

24. DECLARATION UNDER INSOLVENCY AND BANKRUPTCY CODE

No application made nor any proceeding pending under the Insolvency and
Bankruptcy Code, 2016 (31 of 2016) during the year under review.

25. DECLARATION REGARDING SETTLEMENT WITH BANKS/FINANCIAL
INSTITUTIONS

The company has not made any settlement with banks or financial institutions in
the year under review; therefore, no valuation was made.

26. CORPORATE GOVERNANCE REPORT

The Company has ethical governance practices many of which are implemented by
the Company.

The Company is committed to transparency in all its dealings and places high
emphasis on business ethics. A report on corporate governance as per the
provisions of the SEBI (Listing Obligations and Disclosure Requirements]
Regulations, 2015 forms part of this annual report as "Annexure-VI"

ACKNOWLEDGEMENT:

The Board of Directors are grateful for the co-operation and support from the
Bankers, clients and other business partners. The Board takes this opportunity to
express their sincere appreciation for the excellent patronage, total commitment,
dedicated efforts of the executives and employees of the Company at all levels.

Your directors would like to express their gratitude to the Members and are deeply
grateful to them for reposing their confidence and faith in the Company.

The Directors wish to place on record their sincere appreciation of the valuable
services rendered by the employees to the Company.

APPRECIATION

The Directors wish to convey their appreciation to all of the Company's employees
for their enormous personal efforts as well as their collective contribution to the
Company's performance. The Directors would also like to thank the shareholders,
customers, dealers, suppliers, bankers, Government and all the other business
associates for the continuous support given by them to the Company and their
confidence in its management.

By the Order of the
Board of Directors
JFL LIFE SCIENCES LIMITED

SMIRAL ASHWINKUMAR TEJAL SMIRAL PATEL
PATEL

Date: 31.07.2026 Managing Director Whole Time Director

Place: Ahmedabad DIN: 00769486 DIN: 07391559